The pharmaceutical industry is rapidly evolving, with substantial demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, is a key example of this trend. To meet this demand, US-based manufacturing services are gaining traction. These organizat